• Ambea’s takeover offer for Humana was declared unconditional on Oct. 1, 2026.
• Ambea controls more than 90% of Humana shares, triggering a planned squeeze-out of the remaining stock.
• Humana’s board moved to seek a Nasdaq Stockholm delisting at Ambea’s request; last trading day pending exchange confirmation.
• An extraordinary general meeting is set for Oct. 30, 2026, including the election of new board members.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humana AB published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.